GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Characterizing Pathogen-Mediated Production of Secondary Metabolites in the Human Aerodigestive Tract Microbiome

$246,065
Reed M Stubbendieck · Oklahoma State University Stillwater · P20 · FY2024 · GM

Applying Human Factors and Mathematical Modeling Approaches to Prevent Transmission of High-Consequence Pathogens

$246,050
Peter J Pronovost · Johns Hopkins University · U54 · FY2017 · CK

Exploring the role of metagenomic deep sequencing for trachoma

$246,000
Jeremy David Keenan · University Of California, San Francisco · R21 · FY2024 · EY

Comprehensive characterization of Rv0678 bedaquiline resistance-conferring polymorphisms

$246,000
John Zapata Metcalfe · University Of California, San Francisco · R21 · FY2025 · AI

Site-directed spin labeling of ArnT

$246,000
Medical College Of Wisconsin · R01 · FY2004 · AI

Antimicrobial peptides as models for the evolution of gene duplication

$245,840
Robert L Unckless · University Of Kansas Lawrence · R00 · FY2017 · GM

Targeting transcription-coupled DNA supercoiling for discovering antibiotics against bacterial DNA gyrase

$245,784
Fenfei Leng · Florida International University · R21 · FY2018 · AI

Elucidating a unique bacterial strategy that protects susceptible bacteria from antibiotic killing and promotes the genetic transmission of antimicrobial resistance

$245,777
Molly A Hughes · University Of Virginia · R21 · FY2019 · AI

S. aureus virulence factor expression during kidney abscess formation

$245,625
Kim Davis · Johns Hopkins University · R21 · FY2022 · AI

Dissecting a sensory system for Legionella replication vacuole integrity

$245,625
Tamara O'Connor · Johns Hopkins University · R21 · FY2024 · AI

Antibiotic Knowledge and Attitudes among Nursing Home Patients, Family and Staff.

$245,625
Jonathan M Zenilman · Johns Hopkins University · R21 · FY2019 · AG

Toxoplasma in the GI tract: Protective role of a parasite protease inhibitor

$245,625
Isabelle Coppens · Johns Hopkins University · R21 · FY2020 · AI

VTEU: POPULATION PHARMACOKINETIC STUDY

$245,556
Patricia Winokur · University Of Iowa · N01 · FY2018 · AI

The development of multiplexed, label-free isothermal diagnostic for rapid identification of bacterial pathogens

$245,550
Irina Smolina · Boston University (Charles River Campus) · R21 · FY2015 · AI

Targeting host immune cells and DAMP molecules to improve outcome in tuberculosis

$245,438
William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI

Training in Population Biology of Infectious Diseases

$245,312
Leslie A. Real · Emory University · T32 · FY2013 · AI

Maltodextrin based antibiotics

$245,252
Niren Murthy · University Of California Berkeley · R21 · FY2012 · AI

Characterization of LiaR from multidrug-resistant E. faecium

$245,230
Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · R21 · FY2015 · AI

Identification of novel inhibitors of a Vibrio cholerae stress response pathway

$245,202
Jyl S Matson · University Of Toledo Health Sci Campus · R01 · FY2015 · HD

Rational identification of Corynebacterium strains for use as probiotics

$245,116
Patrick C. Seed · Lurie Children'S Hospital Of Chicago · R21 · FY2022 · AI

Organoid Cultivation Core

$245,078
Sarah E Blutt · Baylor College Of Medicine · U19 · FY2021 · AI

Improved Therapeutics and Diagnostics for PneumocystisPneumonia

$245,040
Jay K Kolls · Tulane University Of Louisiana · R01 · FY2017 · AI

Structure and function of antimicrobial peptides

$245,006
Ayyalusamy Ramamoorthy · University Of Michigan At Ann Arbor · R01 · FY2008 · AI

Drosophila model of antibiotic resistant infection

$245,000
Schepens Eye Research Institute · R21 · FY2005 · RR

Characterization of MsbA inhibitors as potential antibiotic leads to treat carbapenem-resistant Enterobacteriaceae (CRE)

$245,000
Terry Roemer · Prokaryotics, Inc. · R21 · FY2020 · AI